SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-071374
Filing Date
2024-06-13
Accepted
2024-06-13 18:03:26
Documents
1
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417165-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417165-5_4seq1.xml 4 4714
  Complete submission text file 0001104659-24-071374.txt   6540
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Countouriotis Athena (Reporting) CIK: 0001571469 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 241042431